{"id":"W1582892440","doi":"10.1007/s12325-015-0224-2","title":"Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study","year":2015,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Fingolimod; Medicine; Tolerability; Adverse effect; Internal medicine; Discontinuation; Multiple sclerosis; Expanded Disability Status Scale; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006069123,0.0001275436,0.0002563964,0.00002835107,0.00006295069,0.00002015732,0.0002722053,0.00003118537,8.348908e-7],"category_scores_gemma":[0.0001887213,0.00008607031,0.00001154893,0.0002093382,0.000147563,0.00002535946,0.0001299953,0.00009797558,1.019116e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001349375,"about_ca_system_score_gemma":0.00003152295,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004857996,"about_ca_topic_score_gemma":0.001716304,"domain_scores_codex":[0.9989645,0.0001323136,0.0003007134,0.0003047286,0.0001282394,0.0001694509],"domain_scores_gemma":[0.9993296,0.00007732095,0.0001781288,0.0003092929,0.00006823459,0.0000374242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00127047,0.0005216539,0.9679755,0.000004580857,0.00001348253,1.990013e-7,0.001740145,0.001101751,0.001398775,0.00000778422,0.000002011098,0.02596363],"study_design_scores_gemma":[0.01350606,0.001169591,0.9770029,0.00008297709,0.000006260135,2.568085e-7,0.002287931,0.0002664827,0.003084978,0.00006132161,0.002325414,0.0002058232],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995979,0.0031731,0.00009138496,0.00003504112,0.00005911037,0.0005593417,0.000008365198,0.00000376779,0.00009092735],"genre_scores_gemma":[0.9975885,0.001151606,0.00106463,0.0001015638,0.00003067294,0.00003353056,0.00001010546,0.00001418741,0.000005271461],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0257578,"threshold_uncertainty_score":0.3509846,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03442763743359083,"score_gpt":0.2837856589733033,"score_spread":0.2493580215397124,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}